Class IITerminatedVoluntary: Firm initiated

Sweetheart USA, LLC: food recall F-0929-2025

Sweetheart USA, LLC of Sagamore Hills, OH recalled Gluten Free Vegan Peanut Butter Jam Cookie, Net Wt. 3.5 oz (200g), packaged individually in plastic. Reason: Undeclared sesame. The FDA listed it as Class II in its Enforcement Report dated Jun 18, 2025; distribution: Ohio.

Record status as published: Terminated (terminated Aug 12, 2025). openFDA data last updated Oct 21, 2026.

Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.

Recall details

Product
Gluten Free Vegan Peanut Butter Jam Cookie, Net Wt. 3.5 oz (200g), packaged individually in plastic
Product quantity
53 units
Reason for recall
Undeclared sesame
Codes, lots and dates on the package
Batch: sw4.28.25
Distribution pattern
Distributed to 11 restaurants in Ohio
Recalling firm
Sweetheart USA, LLC, Sagamore Hills, OH
Classification
Class II — the FDA uses this class for a situation in which using or being exposed to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Voluntary or mandated
Voluntary: Firm initiated
How the firm first notified customers
Telephone

Dates

EventDate
Recall initiated by the firmMay 6, 2025
Classified by the FDAJun 6, 2025
Published in the Enforcement ReportJun 18, 2025
TerminatedAug 12, 2025

All food recall records

OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.

Sources

  • U.S. Food and Drug Administration, openFDA food enforcement reports, recall number F-0929-2025 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
  • Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.